Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated T1D Biotech Company

About Seraxis, Inc.

Seraxis is a private biotechnology company launched in 2013 and located in Germantown, Maryland. The Seraxis mission is to develop a practical and potent cell replacement therapy for insulin-dependent diabetes.